The company’s trial of Haduvio met its primary and secondary endpoints in reducing coughing fits across patients by 53%.
GlobalData predicts that icotrokinra will reach blockbuster status in 2029, with the drug forecast to generate sales of ...
CervoMed has announced positive results from the extension phase 2b RewinD-LB study of neflamapimod for dementia with Lewy ...
THE City of Van Alstyne continues work on bike and pedestrian trails that will eventually link all parks throughout the city.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback